Selected research
Market Outlook & Growth Opportunities
Global Neonatal Intensive Care Market Outlook and Growth Opportunities 2026
Market perspective
The global Neonatal Intensive Care market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Neonatal Intensive Care is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Neonatal Intensive Care is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Neonatal Intensive Care is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Neonatal Intensive Care market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Neonatal Intensive Care market include Jiangsu Yuyue Medical Equipment and Supply Co., Ltd., Beijing Aeonmed Co., Ltd., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Edan Instruments, Inc., Micomme Medical Technology Development Co., Ltd., Guangdong Biolight Meditech Co., Ltd., Shenzhen Comen Medical Instruments Co., Ltd., Ningbo David Medical Device Co., Ltd. and Zhengzhou Dison Instrument and Meter Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Neonatal Intensive Care market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Neonatal Intensive Care and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Neonatal Intensive Care revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Neonatal Intensive Care market.
Neonatal Intensive Care Segment by Company
Jiangsu Yuyue Medical Equipment and Supply Co., Ltd.
Beijing Aeonmed Co., Ltd.
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Edan Instruments, Inc.
Micomme Medical Technology Development Co., Ltd.
Guangdong Biolight Meditech Co., Ltd.
Shenzhen Comen Medical Instruments Co., Ltd.
Ningbo David Medical Device Co., Ltd.
Zhengzhou Dison Instrument and Meter Co., Ltd.
GE Healthcare
Philips
Dragerwerk
Getinge
Hamilton
Neonatal Intensive Care Segment by Type
Baby Care Equipment
Ventilator
Monitor
Others
Neonatal Intensive Care Segment by Application
Public Hospital
Private Hospital
Neonatal Intensive Care Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Neonatal Intensive Care status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Neonatal Intensive Care key companies, revenue, market share, and recent developments.
3. To split the Neonatal Intensive Care breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Neonatal Intensive Care market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Neonatal Intensive Care significant trends, drivers, influence factors in global and regions.
6. To analyze Neonatal Intensive Care competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neonatal Intensive Care market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Neonatal Intensive Care and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neonatal Intensive Care.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Neonatal Intensive Care industry.
Chapter 3: Detailed analysis of Neonatal Intensive Care company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Neonatal Intensive Care in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Neonatal Intensive Care in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Baby Care Equipment
- Ventilator
- Monitor
- Others
Applications
- Public Hospital
- Private Hospital
Companies covered
- Jiangsu Yuyue Medical Equipment and Supply Co., Ltd.
- Beijing Aeonmed Co., Ltd.
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- Edan Instruments, Inc.
- Micomme Medical Technology Development Co., Ltd.
- Guangdong Biolight Meditech Co., Ltd.
- Shenzhen Comen Medical Instruments Co., Ltd.
- Ningbo David Medical Device Co., Ltd.
- Zhengzhou Dison Instrument and Meter Co., Ltd.
- GE Healthcare
- Philips
- Dragerwerk
- Getinge
- Hamilton
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Neonatal Intensive Care Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Neonatal Intensive Care Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Neonatal Intensive Care Market Dynamics
- 2.1 Neonatal Intensive Care Industry Trends
- 2.2 Neonatal Intensive Care Industry Drivers
- 2.3 Neonatal Intensive Care Industry Opportunities and Challenges
- 2.4 Neonatal Intensive Care Industry Restraints
3 Neonatal Intensive Care Market by Company
- 3.1 Global Neonatal Intensive Care Company Revenue Ranking in 2025
- 3.2 Global Neonatal Intensive Care Revenue by Company (2021-2026)
- 3.3 Global Neonatal Intensive Care Company Ranking (2024-2026)
- 3.4 Global Neonatal Intensive Care Company Manufacturing Base and Headquarters
- 3.5 Global Neonatal Intensive Care Company Product Type and Application
- 3.6 Global Neonatal Intensive Care Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Neonatal Intensive Care Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Neonatal Intensive Care Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Neonatal Intensive Care Market by Type
- 4.1 Neonatal Intensive Care Type Introduction
- 4.1.1 Baby Care Equipment
- 4.1.2 Ventilator
- 4.1.3 Monitor
- 4.1.4 Others
- 4.2 Global Neonatal Intensive Care Sales Value by Type
- 4.2.1 Global Neonatal Intensive Care Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Neonatal Intensive Care Sales Value by Type (2021-2032)
- 4.2.3 Global Neonatal Intensive Care Sales Value Share by Type (2021-2032)
5 Neonatal Intensive Care Market by Application
- 5.1 Neonatal Intensive Care Application Introduction
- 5.1.1 Public Hospital
- 5.1.2 Private Hospital
- 5.2 Global Neonatal Intensive Care Sales Value by Application
- 5.2.1 Global Neonatal Intensive Care Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Neonatal Intensive Care Sales Value by Application (2021-2032)
- 5.2.3 Global Neonatal Intensive Care Sales Value Share by Application (2021-2032)
6 Neonatal Intensive Care Regional Value Analysis
- 6.1 Global Neonatal Intensive Care Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Neonatal Intensive Care Sales Value by Region (2021-2032)
- 6.2.1 Global Neonatal Intensive Care Sales Value by Region: 2021-2026
- 6.2.2 Global Neonatal Intensive Care Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Neonatal Intensive Care Sales Value (2021-2032)
- 6.3.2 North America Neonatal Intensive Care Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Neonatal Intensive Care Sales Value (2021-2032)
- 6.4.2 Europe Neonatal Intensive Care Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Neonatal Intensive Care Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Neonatal Intensive Care Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Neonatal Intensive Care Sales Value (2021-2032)
- 6.6.2 South America Neonatal Intensive Care Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Neonatal Intensive Care Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Neonatal Intensive Care Sales Value Share by Country, 2025 VS 2032
7 Neonatal Intensive Care Country-level Value Analysis
- 7.1 Global Neonatal Intensive Care Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Neonatal Intensive Care Sales Value by Country (2021-2032)
- 7.2.1 Global Neonatal Intensive Care Sales Value by Country (2021-2026)
- 7.2.2 Global Neonatal Intensive Care Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Neonatal Intensive Care Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Neonatal Intensive Care Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Neonatal Intensive Care Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Neonatal Intensive Care Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Neonatal Intensive Care Sales Value Growth Rate (2021-2032)
- 7.7.2 France Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Neonatal Intensive Care Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Neonatal Intensive Care Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Neonatal Intensive Care Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Neonatal Intensive Care Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Neonatal Intensive Care Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Neonatal Intensive Care Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Neonatal Intensive Care Sales Value Growth Rate (2021-2032)
- 7.14.2 China Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Neonatal Intensive Care Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Neonatal Intensive Care Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Neonatal Intensive Care Sales Value Growth Rate (2021-2032)
- 7.17.2 India Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Neonatal Intensive Care Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Neonatal Intensive Care Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Neonatal Intensive Care Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Neonatal Intensive Care Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Neonatal Intensive Care Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Neonatal Intensive Care Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Neonatal Intensive Care Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Neonatal Intensive Care Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Neonatal Intensive Care Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Neonatal Intensive Care Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Neonatal Intensive Care Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Neonatal Intensive Care Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Neonatal Intensive Care Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Jiangsu Yuyue Medical Equipment and Supply Co., Ltd.
- 8.1.1 Jiangsu Yuyue Medical Equipment and Supply Co., Ltd. Company Information
- 8.1.2 Jiangsu Yuyue Medical Equipment and Supply Co., Ltd. Business Overview
- 8.1.3 Jiangsu Yuyue Medical Equipment and Supply Co., Ltd. Neonatal Intensive Care Revenue and Gross Margin (2021-2026)
- 8.1.4 Jiangsu Yuyue Medical Equipment and Supply Co., Ltd. Neonatal Intensive Care Product Portfolio
- 8.1.5 Jiangsu Yuyue Medical Equipment and Supply Co., Ltd. Recent Developments
- 8.2 Beijing Aeonmed Co., Ltd.
- 8.2.1 Beijing Aeonmed Co., Ltd. Company Information
- 8.2.2 Beijing Aeonmed Co., Ltd. Business Overview
- 8.2.3 Beijing Aeonmed Co., Ltd. Neonatal Intensive Care Revenue and Gross Margin (2021-2026)
- 8.2.4 Beijing Aeonmed Co., Ltd. Neonatal Intensive Care Product Portfolio
- 8.2.5 Beijing Aeonmed Co., Ltd. Recent Developments
- 8.3 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- 8.3.1 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Company Information
- 8.3.2 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Business Overview
- 8.3.3 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Neonatal Intensive Care Revenue and Gross Margin (2021-2026)
- 8.3.4 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Neonatal Intensive Care Product Portfolio
- 8.3.5 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Recent Developments
- 8.4 Edan Instruments, Inc.
- 8.4.1 Edan Instruments, Inc. Company Information
- 8.4.2 Edan Instruments, Inc. Business Overview
- 8.4.3 Edan Instruments, Inc. Neonatal Intensive Care Revenue and Gross Margin (2021-2026)
- 8.4.4 Edan Instruments, Inc. Neonatal Intensive Care Product Portfolio
- 8.4.5 Edan Instruments, Inc. Recent Developments
- 8.5 Micomme Medical Technology Development Co., Ltd.
- 8.5.1 Micomme Medical Technology Development Co., Ltd. Company Information
- 8.5.2 Micomme Medical Technology Development Co., Ltd. Business Overview
- 8.5.3 Micomme Medical Technology Development Co., Ltd. Neonatal Intensive Care Revenue and Gross Margin (2021-2026)
- 8.5.4 Micomme Medical Technology Development Co., Ltd. Neonatal Intensive Care Product Portfolio
- 8.5.5 Micomme Medical Technology Development Co., Ltd. Recent Developments
- 8.6 Guangdong Biolight Meditech Co., Ltd.
- 8.6.1 Guangdong Biolight Meditech Co., Ltd. Company Information
- 8.6.2 Guangdong Biolight Meditech Co., Ltd. Business Overview
- 8.6.3 Guangdong Biolight Meditech Co., Ltd. Neonatal Intensive Care Revenue and Gross Margin (2021-2026)
- 8.6.4 Guangdong Biolight Meditech Co., Ltd. Neonatal Intensive Care Product Portfolio
- 8.6.5 Guangdong Biolight Meditech Co., Ltd. Recent Developments
- 8.7 Shenzhen Comen Medical Instruments Co., Ltd.
- 8.7.1 Shenzhen Comen Medical Instruments Co., Ltd. Company Information
- 8.7.2 Shenzhen Comen Medical Instruments Co., Ltd. Business Overview
- 8.7.3 Shenzhen Comen Medical Instruments Co., Ltd. Neonatal Intensive Care Revenue and Gross Margin (2021-2026)
- 8.7.4 Shenzhen Comen Medical Instruments Co., Ltd. Neonatal Intensive Care Product Portfolio
- 8.7.5 Shenzhen Comen Medical Instruments Co., Ltd. Recent Developments
- 8.8 Ningbo David Medical Device Co., Ltd.
- 8.8.1 Ningbo David Medical Device Co., Ltd. Company Information
- 8.8.2 Ningbo David Medical Device Co., Ltd. Business Overview
- 8.8.3 Ningbo David Medical Device Co., Ltd. Neonatal Intensive Care Revenue and Gross Margin (2021-2026)
- 8.8.4 Ningbo David Medical Device Co., Ltd. Neonatal Intensive Care Product Portfolio
- 8.8.5 Ningbo David Medical Device Co., Ltd. Recent Developments
- 8.9 Zhengzhou Dison Instrument and Meter Co., Ltd.
- 8.9.1 Zhengzhou Dison Instrument and Meter Co., Ltd. Company Information
- 8.9.2 Zhengzhou Dison Instrument and Meter Co., Ltd. Business Overview
- 8.9.3 Zhengzhou Dison Instrument and Meter Co., Ltd. Neonatal Intensive Care Revenue and Gross Margin (2021-2026)
- 8.9.4 Zhengzhou Dison Instrument and Meter Co., Ltd. Neonatal Intensive Care Product Portfolio
- 8.9.5 Zhengzhou Dison Instrument and Meter Co., Ltd. Recent Developments
- 8.10 GE Healthcare
- 8.10.1 GE Healthcare Company Information
- 8.10.2 GE Healthcare Business Overview
- 8.10.3 GE Healthcare Neonatal Intensive Care Revenue and Gross Margin (2021-2026)
- 8.10.4 GE Healthcare Neonatal Intensive Care Product Portfolio
- 8.10.5 GE Healthcare Recent Developments
- 8.11 Philips
- 8.11.1 Philips Company Information
- 8.11.2 Philips Business Overview
- 8.11.3 Philips Neonatal Intensive Care Revenue and Gross Margin (2021-2026)
- 8.11.4 Philips Neonatal Intensive Care Product Portfolio
- 8.11.5 Philips Recent Developments
- 8.12 Dragerwerk
- 8.12.1 Dragerwerk Company Information
- 8.12.2 Dragerwerk Business Overview
- 8.12.3 Dragerwerk Neonatal Intensive Care Revenue and Gross Margin (2021-2026)
- 8.12.4 Dragerwerk Neonatal Intensive Care Product Portfolio
- 8.12.5 Dragerwerk Recent Developments
- 8.13 Getinge
- 8.13.1 Getinge Company Information
- 8.13.2 Getinge Business Overview
- 8.13.3 Getinge Neonatal Intensive Care Revenue and Gross Margin (2021-2026)
- 8.13.4 Getinge Neonatal Intensive Care Product Portfolio
- 8.13.5 Getinge Recent Developments
- 8.14 Hamilton
- 8.14.1 Hamilton Company Information
- 8.14.2 Hamilton Business Overview
- 8.14.3 Hamilton Neonatal Intensive Care Revenue and Gross Margin (2021-2026)
- 8.14.4 Hamilton Neonatal Intensive Care Product Portfolio
- 8.14.5 Hamilton Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst